Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does POLATUZUMAB VEDOTIN Cause Disease progression? 1,131 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 1,131 reports of Disease progression have been filed in association with POLATUZUMAB VEDOTIN (POLIVY). This represents 23.9% of all adverse event reports for POLATUZUMAB VEDOTIN.

1,131
Reports of Disease progression with POLATUZUMAB VEDOTIN
23.9%
of all POLATUZUMAB VEDOTIN reports
234
Deaths
146
Hospitalizations

How Dangerous Is Disease progression From POLATUZUMAB VEDOTIN?

Of the 1,131 reports, 234 (20.7%) resulted in death, 146 (12.9%) required hospitalization, and 26 (2.3%) were considered life-threatening.

Is Disease progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for POLATUZUMAB VEDOTIN. However, 1,131 reports have been filed with the FAERS database.

What Other Side Effects Does POLATUZUMAB VEDOTIN Cause?

Off label use (692) Anaemia (344) Blood lactate dehydrogenase increased (307) Drug ineffective (305) Neutropenia (303) Death (295) Covid-19 (286) Febrile neutropenia (286) Pyrexia (285) Thrombocytopenia (265)

What Other Drugs Cause Disease progression?

RITUXIMAB (7,282) CYCLOPHOSPHAMIDE (7,100) DOXORUBICIN (6,165) VINCRISTINE (5,252) PREDNISONE (5,096) BEVACIZUMAB (4,653) DEXAMETHASONE (4,545) CARBOPLATIN (4,538) CAPECITABINE (3,808) ETOPOSIDE (3,776)

Which POLATUZUMAB VEDOTIN Alternatives Have Lower Disease progression Risk?

POLATUZUMAB VEDOTIN vs POLATUZUMAB VEDOTIN-PIIQ POLATUZUMAB VEDOTIN vs POLIDOCANOL POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL 3350 POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL 3350\POTASSIUM\SODIUM BICARBONATE\SODIUM

Related Pages

POLATUZUMAB VEDOTIN Full Profile All Disease progression Reports All Drugs Causing Disease progression POLATUZUMAB VEDOTIN Demographics